+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microbiome Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 102 Pages
  • October 2023
  • Region: Global
  • Prof Research
  • ID: 5896741

Quick Summary:

As the world of business is continually swept by transformative innovations, the evolution of the Microbiome Drug industry stands out. Well, here's your opportunity to tap into this dynamic arena, anticipate trends, understand market forces, and stay ahead of the game with our comprehensive market research report.

Our report provides an in-depth analysis with a geographic lens, detailing supply, demand, pricing and major players from regions covering North America, South America, Asia and Pacific, Europe, and MEA. Key countries including the United States, China, Japan, India, and Germany, among others are individually assessed, furnishing detailed insights into local markets.

Access up-to-date competitor analysis on international Microbiome Drug giants, including Pfizer and Second Genome, as well as budding players in the field. We dive deep into company profiles, business information, SWOT analysis, and market share data. We have also dissected the industry into its applications and types segments, giving you the strategic edge you need in decision making. Secure your business’s future—let our Microbiome Drug market research report guide your next strategic moves.

This report describes the global market size of Microbiome Drug from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.

For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of Microbiome Drug as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Applications Segment:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Other

Types Segment:

  • Probiotics
  • Prebiotics
  • Small Molecules
  • Biological Drugs
  • Other

Companies Covered:

  • Pfizer
  • Second Genome
  • Seres Therapeutics
  • MaaT Pharma
  • Enterome Bioscience
  • MicroBiome Therapeutics
  • Ritter Pharmaceuticals
  • Rebiotix
  • OpenBiome
Base Year: 2023
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Microbiome Drug Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Microbiome Drug Market in North America (2018-2028)
8.1 Microbiome Drug Market Size
8.2 Microbiome Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 Microbiome Drug Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Microbiome Drug Market in South America (2018-2028)
9.1 Microbiome Drug Market Size
9.2 Microbiome Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 Microbiome Drug Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Microbiome Drug Market in Asia & Pacific (2018-2028)
10.1 Microbiome Drug Market Size
10.2 Microbiome Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 Microbiome Drug Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Microbiome Drug Market in Europe (2018-2028)
11.1 Microbiome Drug Market Size
11.2 Microbiome Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 Microbiome Drug Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Microbiome Drug Market in MEA (2018-2028)
12.1 Microbiome Drug Market Size
12.2 Microbiome Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 Microbiome Drug Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Microbiome Drug Market (2018-2023)
13.1 Microbiome Drug Market Size
13.2 Microbiome Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 Microbiome Drug Market Size by Type
Chapter 14 Global Microbiome Drug Market Forecast (2023-2028)
14.1 Microbiome Drug Market Size Forecast
14.2 Microbiome Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 Microbiome Drug Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Pfizer
15.1.1 Company Profile
15.1.2 Main Business and Microbiome Drug Information
15.1.3 SWOT Analysis of Pfizer
15.1.4 Pfizer Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.2 Second Genome
15.2.1 Company Profile
15.2.2 Main Business and Microbiome Drug Information
15.2.3 SWOT Analysis of Second Genome
15.2.4 Second Genome Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.3 Seres Therapeutics
15.3.1 Company Profile
15.3.2 Main Business and Microbiome Drug Information
15.3.3 SWOT Analysis of Seres Therapeutics
15.3.4 Seres Therapeutics Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.4 MaaT Pharma
15.4.1 Company Profile
15.4.2 Main Business and Microbiome Drug Information
15.4.3 SWOT Analysis of MaaT Pharma
15.4.4 MaaT Pharma Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.5 Enterome Bioscience
15.5.1 Company Profile
15.5.2 Main Business and Microbiome Drug Information
15.5.3 SWOT Analysis of Enterome Bioscience
15.5.4 Enterome Bioscience Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.6 MicroBiome Therapeutics
15.6.1 Company Profile
15.6.2 Main Business and Microbiome Drug Information
15.6.3 SWOT Analysis of MicroBiome Therapeutics
15.6.4 MicroBiome Therapeutics Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.7 Ritter Pharmaceuticals
15.7.1 Company Profile
15.7.2 Main Business and Microbiome Drug Information
15.7.3 SWOT Analysis of Ritter Pharmaceuticals
15.7.4 Ritter Pharmaceuticals Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.8 Rebiotix
15.8.1 Company Profile
15.8.2 Main Business and Microbiome Drug Information
15.8.3 SWOT Analysis of Rebiotix
15.8.4 Rebiotix Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
15.9 OpenBiome
15.9.1 Company Profile
15.9.2 Main Business and Microbiome Drug Information
15.9.3 SWOT Analysis of OpenBiome
15.9.4 OpenBiome Microbiome Drug Revenue, Gross Margin and Market Share (2018-2023)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Microbiome Drug Report
Table Data Sources of Microbiome Drug Report
Table Major Assumptions of Microbiome Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Microbiome Drug Picture
Table Microbiome Drug Classification
Table Microbiome Drug Applications
Table Drivers of Microbiome Drug Market
Table Restraints of Microbiome Drug Market
Table Opportunities of Microbiome Drug Market
Table Threats of Microbiome Drug Market
Table Covid-19 Impact For Microbiome Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of Microbiome Drug
Table Cost Structure Analysis of Microbiome Drug
Table Key End Users
Table Latest News of Microbiome Drug Market
Table Merger and Acquisition
Table Planned/Future Project of Microbiome Drug Market
Table Policy of Microbiome Drug Market
Table 2018-2028 North America Microbiome Drug Market Size
Figure 2018-2028 North America Microbiome Drug Market Size and CAGR
Table 2018-2028 North America Microbiome Drug Market Size by Application
Table 2018-2023 North America Microbiome Drug Key Players Revenue
Table 2018-2023 North America Microbiome Drug Key Players Market Share
Table 2018-2028 North America Microbiome Drug Market Size by Type
Table 2018-2028 United States Microbiome Drug Market Size
Table 2018-2028 Canada Microbiome Drug Market Size
Table 2018-2028 Mexico Microbiome Drug Market Size
Table 2018-2028 South America Microbiome Drug Market Size
Figure 2018-2028 South America Microbiome Drug Market Size and CAGR
Table 2018-2028 South America Microbiome Drug Market Size by Application
Table 2018-2023 South America Microbiome Drug Key Players Revenue
Table 2018-2023 South America Microbiome Drug Key Players Market Share
Table 2018-2028 South America Microbiome Drug Market Size by Type
Table 2018-2028 Brazil Microbiome Drug Market Size
Table 2018-2028 Argentina Microbiome Drug Market Size
Table 2018-2028 Chile Microbiome Drug Market Size
Table 2018-2028 Peru Microbiome Drug Market Size
Table 2018-2028 Asia & Pacific Microbiome Drug Market Size
Figure 2018-2028 Asia & Pacific Microbiome Drug Market Size and CAGR
Table 2018-2028 Asia & Pacific Microbiome Drug Market Size by Application
Table 2018-2023 Asia & Pacific Microbiome Drug Key Players Revenue
Table 2018-2023 Asia & Pacific Microbiome Drug Key Players Market Share
Table 2018-2028 Asia & Pacific Microbiome Drug Market Size by Type
Table 2018-2028 China Microbiome Drug Market Size
Table 2018-2028 India Microbiome Drug Market Size
Table 2018-2028 Japan Microbiome Drug Market Size
Table 2018-2028 South Korea Microbiome Drug Market Size
Table 2018-2028 Southeast Asia Microbiome Drug Market Size
Table 2018-2028 Australia Microbiome Drug Market Size
Table 2018-2028 Europe Microbiome Drug Market Size
Figure 2018-2028 Europe Microbiome Drug Market Size and CAGR
Table 2018-2028 Europe Microbiome Drug Market Size by Application
Table 2018-2023 Europe Microbiome Drug Key Players Revenue
Table 2018-2023 Europe Microbiome Drug Key Players Market Share
Table 2018-2028 Europe Microbiome Drug Market Size by Type
Table 2018-2028 Germany Microbiome Drug Market Size
Table 2018-2028 France Microbiome Drug Market Size
Table 2018-2028 United Kingdom Microbiome Drug Market Size
Table 2018-2028 Italy Microbiome Drug Market Size
Table 2018-2028 Spain Microbiome Drug Market Size
Table 2018-2028 Belgium Microbiome Drug Market Size
Table 2018-2028 Netherlands Microbiome Drug Market Size
Table 2018-2028 Austria Microbiome Drug Market Size
Table 2018-2028 Poland Microbiome Drug Market Size
Table 2018-2028 Russia Microbiome Drug Market Size
Table 2018-2028 MEA Microbiome Drug Market Size
Figure 2018-2028 MEA Microbiome Drug Market Size and CAGR
Table 2018-2028 MEA Microbiome Drug Market Size by Application
Table 2018-2023 MEA Microbiome Drug Key Players Revenue
Table 2018-2023 MEA Microbiome Drug Key Players Market Share
Table 2018-2028 MEA Microbiome Drug Market Size by Type
Table 2018-2028 Egypt Microbiome Drug Market Size
Table 2018-2028 Israel Microbiome Drug Market Size
Table 2018-2028 South Africa Microbiome Drug Market Size
Table 2018-2028 Gulf Cooperation Council Countries Microbiome Drug Market Size
Table 2018-2028 Turkey Microbiome Drug Market Size
Table 2018-2023 Global Microbiome Drug Market Size by Region
Table 2018-2023 Global Microbiome Drug Market Size Share by Region
Table 2018-2023 Global Microbiome Drug Market Size by Application
Table 2018-2023 Global Microbiome Drug Market Share by Application
Table 2018-2023 Global Microbiome Drug Key Vendors Revenue
Figure 2018-2023 Global Microbiome Drug Market Size and Growth Rate
Table 2018-2023 Global Microbiome Drug Key Vendors Market Share
Table 2018-2023 Global Microbiome Drug Market Size by Type
Table 2018-2023 Global Microbiome Drug Market Share by Type
Table 2023-2028 Global Microbiome Drug Market Size by Region
Table 2023-2028 Global Microbiome Drug Market Size Share by Region
Table 2023-2028 Global Microbiome Drug Market Size by Application
Table 2023-2028 Global Microbiome Drug Market Share by Application
Table 2023-2028 Global Microbiome Drug Key Vendors Revenue
Figure 2023-2028 Global Microbiome Drug Market Size and Growth Rate
Table 2023-2028 Global Microbiome Drug Key Vendors Market Share
Table 2023-2028 Global Microbiome Drug Market Size by Type
Table 2023-2028 Microbiome Drug Global Market Share by Type

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer
  • Second Genome
  • Seres Therapeutics
  • MaaT Pharma
  • Enterome Bioscience
  • MicroBiome Therapeutics
  • Ritter Pharmaceuticals
  • Rebiotix
  • OpenBiome

Methodology

Loading
LOADING...